Tissue that heals badly usually has one thing in common: not enough blood reaching it. Tendon, ligament and cartilage are all poorly vascularised, and all three are slow to repair.
That observation ties this research area together. The compounds here are studied largely for what they do to blood vessel formation and cell migration, the two processes underneath how a wound closes.
BPC-157
Fifteen amino acids, derived from a protein found in gastric juice. Most of its literature concerns angiogenesis, and it is unusually stable, which made early oral-route work possible where most peptides would not survive the stomach.
TB-500
The active fragment of thymosin beta-4, working through actin. Where BPC-157 research leans towards vessel growth, TB-500 research leans towards how quickly cells can move into the space.
Why they are studied together
Vessel growth and cell migration are two halves of the same process. A wound needs a blood supply and it needs cells arriving to rebuild, and a model looking at one usually has something to say about the other. That is why the two turn up in the same papers, and why they are commonly supplied as a blend.
What the certificates show
Both are straightforward peptides with clean HPLC traces and unambiguous mass confirmation. On TB-500 the molecular weight is the figure to check first, since it distinguishes the fragment from the full protein. On BPC-157 check the sequence reads GEPPPGKPADDAGLV.